Ad
related to: moderna news
Search results
The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
Zacks via Yahoo Finance· 2 hours agoEvery day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and...
Could Novavax Become the Next Moderna?
Motley Fool via Yahoo Finance· 4 hours agoThe stock since has declined from its peak, but still remains up more than 400% over five years -- and Moderna's solid late-stage pipeline and promise to...
Moderna and OpenAI Are Teaming Up, but Does That Make the Stock a Buy? | The Motley Fool
The Motley Fool· 5 days agoModerna (MRNA -4.38%) and OpenAI are collaborating to bring artificial intelligence (AI) to every...
NBC Securities Inc. Raises Stake in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 6 hours agoNBC Securities Inc. grew its holdings in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 20.2% during the 4th quarter, according to the company in its most recent 13F filing ...
Is This a Setback for Moderna?
The Motley Fool via AOL· 3 days agoIt's also important to keep in mind that the RSV market size is $10 billion, meaning there's room for all three players to carve out market share and...
Moderna (NASDAQ:MRNA) Upgraded to Hold by Evercore ISI
ETF DAILY NEWS· 1 day agoEvercore ISI upgraded shares of Moderna (NASDAQ:MRNA – Free Report) to a hold rating in a research note released on Monday, Zacks.com reports. Canaccord Genuity Group lifted ...
Trending: Moderna's Proposed RSV Vaccine Faces Delayed FDA Review
Morningstar· 7 days ago13:53 ET -- Moderna is one of the most mentioned companies in the U.S. across all news items in the past 12 hours, according to Factiva data. The company ...
Moderna Tumbles After The FDA Throws A Curveball On Its Second Product
Investor's Business Daily· 7 days ago"Although regulatory delays are disappointing and usually create noise around the probability of...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 3 days agoOne analyst called the results "transformational." And Moderna stock surged more than 9% on Dec. 19,...
Moderna's RSV Vaccine Approval Faces Setback as FDA Delays Decision
Homenewshere.com· 7 days agoModerna announced that the FDA had delayed approval of its RSV vaccine to the end of May due to...
